West Pharmaceutical Services | WST - Selling And Administration Expenses

Stock Price
306.16
Daily Change
-3.54 -1.14%
Monthly
23.94%
Yearly
42.70%
Q2 Forecast
267.71

West Pharmaceutical Services reported $99.5M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Align Technology USD 441.68M 23.88M Dec/2025
Avanos Medical USD 78.8M 1.2M Dec/2025
Baxter International USD 761M 53M Dec/2025
Becton, Dickinson and Co. USD 1.39B 27M Dec/2025
Cerus USD 19.33M 1.55M Dec/2024
Charles River Laboratories USD 196.14M 18.55M Dec/2025
Cooper Companies USD 373.1M 46.1M Dec/2025
Dentsply International USD 383M 28M Dec/2025
Haemonetics USD 109.15M 7.54M Dec/2025
ICU Medical USD 155.81M 3.04M Dec/2025
Insulet USD 331.4M 16.2M Dec/2025
Integra LifeSciences USD 156.45M 12.6M Dec/2025
IQVIA Holdings USD 468M 46M Dec/2025
J&J USD 6.03B 719M Mar/2026
Medtronic 2.97B 159M Sep/2025
Merit Medical Systems USD 114.83M 7.45M Dec/2025
Neogen USD 98.5M 9M Dec/2025
OraSure Technologies USD 13.21M 3.29M Dec/2025
Quidel USD 194.4M 7.5M Dec/2025
Repligen USD 74.36M 703K Dec/2025
Rockwell Medical USD 4.04M 330K Jun/2024
Solventum Corp USD 759M 15M Dec/2025
STAAR Surgical USD 38.94M 20.44M Dec/2025
Terumo JPY 105.26B 7.38B Dec/2025
Utah Medical Products USD 2.61M 741K Dec/2025
West Pharmaceutical Services USD 99.5M 7M Mar/2026